CM
NKGN

Crestline Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Crestline Management’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-76,000
Closed -$756K – 219
2022
Q4 		$756K Buy
+76,000
New +$756K 0.11% 130